CJC-1295 Ipamorelin (5+5) MG

Categories:

CJC-1295 (No DAC) / Ipamorelin is a research-grade peptide blend
containing CJC-1295 (5 mg) and Ipamorelin (5 mg). Supplied exclusively for
laboratory and in-vitro research use.

$55.00

⚠️ RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

CJC-1295 / Ipamorelin – Research Grade Peptide Blend (5 mg + 5 mg)

CJC-1295 (No DAC) and Ipamorelin are
synthetic research peptides supplied together in a quantified blend
intended exclusively for controlled laboratory and in-vitro research
environments. Each peptide is provided at a content of 5 mg
per vial.

CJC-1295 (No DAC) is a synthetic peptide analog of growth hormone-releasing
hormone (GHRH), while Ipamorelin is a pentapeptide studied in experimental
models related to peptide-receptor interaction and signaling behavior.
In research settings, this peptide combination is examined in non-clinical
laboratory systems focused on molecular signaling pathways and peptide
interaction dynamics under strictly controlled scientific conditions.

This peptide blend is supplied solely for laboratory research, analytical
testing, and in-vitro scientific investigation. It is not intended for
human or animal use and is not approved for therapeutic, diagnostic,
cosmetic, or medical applications.

For research use only. Not for human or animal consumption.

Chemical & Peptide Information

Peptide 1 CJC-1295 (No DAC)
Peptide 2 Ipamorelin
Peptide Type Synthetic Peptide Blend
CJC-1295 Length 29 Amino Acids
Ipamorelin Length 5 Amino Acids
CJC-1295 Molecular Weight ~3,357 Da
Ipamorelin Molecular Weight ~711 Da
Content CJC-1295 (5 mg) + Ipamorelin (5 mg)
Form Lyophilized Powder (Research-Grade)

Important Notice: CJC-1295 supplied in this blend refers
specifically to the non-DAC (No Drug Affinity Complex)
variant and is chemically distinct from CJC-1295 DAC formulations.
Researchers should confirm experimental requirements prior to use.

Research Overview

In experimental and preclinical research contexts, the CJC-1295 /
Ipamorelin peptide combination is examined in laboratory systems
investigating peptide-mediated signaling behavior, receptor interaction
models, and molecular response dynamics. All studies are conducted
exclusively in non-clinical, in-vitro research environments.

Key Research Focus Areas

  • Peptide-receptor interaction analysis
  • Molecular signaling pathway research
  • Experimental peptide interaction models
  • Peptide stability and degradation studies
  • In-vitro biochemical pathway investigation

All information associated with this peptide blend is derived from
experimental and preclinical research contexts only. No claims are made
regarding medical, therapeutic, cosmetic, or clinical outcomes.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 Ipamorelin (5+5) MG”

Your email address will not be published. Required fields are marked *

Age Verification!

*By continuing, you confirm eligibility and legal compliance.